
FDA Greenlights Updated COVID-19 Vaccines for Fall and Winter Campaign
FDA approves updated Pfizer and Moderna COVID-19 vaccines targeting the KP.2 variant for upcoming fall and winter vaccinations, while Novavax awaits authorization.
My Global News: Voices of a New Era
π Stay Ahead, Stay Global π
FDA approves updated Pfizer and Moderna COVID-19 vaccines targeting the KP.2 variant for upcoming fall and winter vaccinations, while Novavax awaits authorization.